Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
By L. Bellamy, J. Casas, A. Hingorani, David J. Williams. British medical journal, 2007
2,374 citations recorded by the source corpus.
Objective To quantify the risk of future cardiovascular diseases, cancer, and mortality after pre-eclampsia. Design Systematic review and meta-analysis. Data sources Embase and Medline without language restrictions, including papers published between 1960 and December 2006, and hand searching of reference lists of relevant articles and reviews for additional reports. Review methods Prospective and retrospective cohort studies were included, providing a dataset of 3 488 160 women, with 198 252 affected by pre-eclampsia (exposure group) and 29 495 episodes of cardiovascular disease and cancer (study outcomes). Results After pre-eclampsia women have an increased risk of vascular disease. The relative risks (95% confidence intervals) for hypertension were 3.70 (2.70 to 5.05) after 14.1 years weighted mean follow-up, for ischaemic heart disease 2.16 (1.86 to 2.52) after 11.7 years, for stroke 1.81 (1.45 to 2.27) after 10.4 years, and for venous thromboembolism 1.79 (1.37 to 2.33) after 4.7 years. No increase in risk of any cancer was found (0.96, 0.73 to 1.27), including breast cancer (1.04, 0.78 to 1.39) 17 years after pre-eclampsia. Overall mortality after pre-eclampsia was increased: 1.49 (1.05 to 2.14) after 14.5 years. Conclusions A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, or an effect of pre-eclampsia on disease development, or both. No association was found between pre-eclampsia and future cancer.
Subfields: Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/d9e2ad67777b50bb3ba731bbc9b5b1963bd3bfbb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Obstetrics and Gynecology
In Pediatrics, Perinatology and Child Health
Citations in the corpus
- Cardiovascular disease in women (2010, neutral): “33) relative risk for venous thromboembolism after 5 years.(71) Earlier occurrence of preeclampsia in pregnancy is associated with poorer outcomes; in addition, the severity of preeclampsia is correlated with the severity of CVD later in life.”
- The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “• Advice to women with gestational hypertension or preeclampsia that they have increased risks of cardiovascular disease, death, stroke [33,101,102], diabetes, venous thromboembolic disease (VTE) and CKD compared with women who have had normotensive pregnancies [103].”
- Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis (2013, methodology): “A previous review reported that pre-eclampsia resulting in delivery before 37 weeks gestation was more strongly associated with future CVD than those cases with more severe hypertension or proteinuria [2].”
- Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2014, background): “For example, preeclampsia clearly increases risk of stroke in the peripartum period and has been listed as a risk factor for CVD in women in the 2011 AHA “Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women”(21); however, relatively limited data on long-term risk of ”